Coronavirus Latest News

Coronavirus live news: Pfizer and AstraZeneca jab offer protection against India Covid variant, PHE finds

Latest updates: Pfizer vaccine 88% effective against symptomatic disease from the India variant after second dose, AstraZeneca jab 60% effective

Some teenagers and young adults who received Covid-19 vaccines have experienced heart inflammation, a US Centers for Disease Control and Prevention advisory group has said, recommending further study of the rare condition.

Reuters reports:

In a statement dated 17 May, the CDC’s advisory committee on immunisation practices said it had looked into reports that a few young vaccine recipients, predominantly male adolescents and young adults, developed myocarditis, an inflammation of the heart muscle.

The condition often goes away without complications and can be caused by a variety of viruses, the CDC group said.

Related: CDC studying reports of heart inflammation in young Covid vaccine recipients

Good morning, good afternoon and good evening to everyone joining our live coverage today of coronavirus and political news from around the world, centred on events in the UK.

One of the top stories this morning is news of a Public Health England student that has found both the Pfizer and AstraZeneca jabs are highly effective at protecting people from the strain of the Covid-19 virus first found in India.

Related: Pfizer and AstraZeneca ‘highly effective’ against India Covid variant

Continue reading…

Read the original article at The Guardian

Related Articles

Back to top button
Close